Benjamin Edwards Inc Charles River Laboratories International, Inc. Transaction History
Benjamin Edwards Inc
- $503 Million
- Q1 2024
A detailed history of Benjamin Edwards Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 393 shares of CRL stock, worth $79,327. This represents 0.02% of its overall portfolio holdings.
Number of Shares
393
Previous 380
3.42%
Holding current value
$79,327
Previous $90,000
17.78%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
730Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.04 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$423 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$379 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$305 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...